Clinical and Genetic Epidemiology

Myrna M. Weissman, Ph.D., Chief of Psychiatric Research
Phillip B. Adams, Ph.D., Research Scientist IV
Kathryn Betts, D.Clin.Psy., Research Scientist I
Adriana Feder, M.D., Assistant Clinical Professor of Psychiatry in Medicine
Marc Gameroff, Ph.D., Research Scientist III
Risë Goldstein, Ph.D., Adjunct Assistant Professor
David Greenberg, Ph.D., Research Scientist VI
Susan E. Hodge, D.Sc., Research Scientist VII
Dana March, M.P.H., Staff Associate
Lisa Miller, Ph.D., Adjunct Associate Professor
Laura H. Mufson, Ph.D., Research Scientist V
Yoko Nomura, Ph.D., M.P.H., Research Scientist II
Mark Olfson, M.D., M.P.H., Psychiatrist II
Deb Pal, MA, MSc, Ph.D., MRCP, Associate Research Scientist
Daniel Pilowsky, M.D., M.P.H., Psychiatrist II
Helen Verdeli, Ph.D., Assistant Professor of Clinical Psychiatry
Virginia Warner, M.P.H., Research Scientist III
Priya J. Wickramaratne, Ph.D., Research Scientist V

OVERVIEW
The Department of Clinical & Genetic Epidemiology was established in 1987 to gain understanding of the rates and risk factors for psychiatric disorders; primarily mood and anxiety disorders using techniques of epidemiology and genetics and to apply these findings to develop and test empirically-based treatment and prevention interventions. There are projects in four areas: genetics; high risk longitudinal; treatment; and epidemiology/health services.

CURRENT RESEARCH
Genetic Studies

The Mathematical Genetics Unit Led by Drs. Greenberg and Hodge, this unit is a collaborative program to enhance mathematical capacity to study the genetics of complex human diseases. Drs. Hodge, Greenberg and Ottman were funded by NIMH in 2002 to establish a much-needed training component for pre and post-doctoral fellows in statistical genetics. (http://cpmcnet.columbia.edu/dept/sph/epi/gcd/).

Linkage and Segregation in Complex Genetic Diseases (S. E. Hodge, P.I.) The objective is to develop new methods to resolve complications arising in the genetic study of complex diseases, with particular focus on linkage analysis, sex differences in recombination fraction, ascertainment and likelihood, and single nucleotide polymorphisms. Addressing the important problems in human genetics, this field moves to accommodate new types of genetic information, large data sets, and analysis of complex common diseases.

Psychiatric Genetics and Family Studies: Robust Methods (S.E. Hodge, P.I.) Families represent an important source of information for unraveling the etiology of the psychiatric disorders. Two major tools used by mathematical geneticists and genetic epidemiologists to exploit family studies are linkage analysis and segregation analysis. Dr. Hodge’s work continues to address specific problems arising in both these methods of analysis. The overriding theme of her work is to evaluate the robustness of analysis methods, that is, how well do different methods perform when their assumptions are not met? This is important because psychiatric genetics today is dealing with complex diseases for which the genetics are not known or are poorly understood.

Genetic Study of Panic Disorder (M. Weissman, P.I.) The overall aim is to understand the genetic contribution to panic disorder (PD) using 130 well-characterized multiplex families, family-based triads and advanced molecular genetic approaches. Several loci exhibit maximum lod scores of 3.0 or greater under several analytic models (maximum lod scores 4.0). Our initial findings of a possible syndrome involving PD, bladder/kidney problems, mitral valve proplapse, thyroid disorder and migraine was replicated in an extended sample of 60 multiplex families. Since the bladder/kidney problems yielded the highest lod scores, we developed a collaboration with urology, who upon review of the records, thought that interstitial cystitis (IC) best described the problems. A case control study of patients diagnosed with IC by board-certified urologists using urodynamics and/or cystoscopy found increased rates of PD and some of the syndrome disorders in the probands and their first-degree relatives. This finding published in Archives was featured in a report in the Scientist. A pilot open clinical trial of SSRI in patients with IC has been initiated.

Genetics of Fear & Anxiety (M. Weissman, P.I.) We have developed a new collaboration and a Program Project with Drs. Gilliam, Kandel, Hen and Fyer to understand the genetic basis of fear and anxiety disorder in humans by identifying variant forms of genes that may contribute to pathological anxiety. The central hypothesis is that there are similarities in fear conditioning circuitry in animals and humans and that genes involved in the pathway associated with fear conditioning or innate fear may be involved in the development of human anxiety disorders particularly panic and social anxiety disorder. We are collecting a clinical sample, conducting diagnostic interviews and collecting bloods in a case-control design.

Genetics of Recurrent Early Onset Major Depression (MDD-RE) (M. Weissman, P.I.) As part of a multicenter sibpair study we completed collection of nearly 1,000 affected sibpairs with early-onset recurrent depression (onset <30 years of age). Results of the genome scan are being analyzed (Holmans et al, 2004).

Epidemiologic Methods in Psychiatric Family Studies (P. Wickramaratne, P.I.) The study of familial aggregation of disease is a first step in determining whether an illness may be genetic. We are evaluating epidemiologic approaches to determining the presence of and estimating measures of familial aggregation. We showed that current approaches to analyzing data from family studies of psychiatric disorders may not be appropriate when the disorder is suspected of having a genetic component, e.g., we have shown that the concept of familial aggregation as applied to parent-offspring disease aggregation (disease transmission) is quite different from the concept of sibling disease aggregation (disease clustering) and methods for determining the presence of familial aggregation should be tailored to the specific type of aggregation that one wishes to detect.

High Risk Longitudinal Studies
Offspring at High and Low Risk for Depression (M. Weissman, P.I.) We have completed a 20-year follow-up of grandparents, parents and, more recently, grandchildren at high and low risk for depression by virtue of their grandparents (the probands) depression diagnosis. Major findings show the high rates of psychopathology (primarily anxiety disorder) in the grandchildren from the highest risk groups (both generations 1 and 2 affected). The grandchildren are young (mean age 12 years) and show the same pattern of onset as in the previous two generations, with a prepubertal onset of anxiety disorders followed by adolescent onset MDD. Neuropsychological (EEG and startle) studies have been completed by Drs. Bruder and Grillon and are under analysis. An imaging study using functional and anatomical MRI is underway in collaboration with Bradley Peterson.

Depressed Children Grown Up – A.Feder received a NARSAD Young Investigator Award to study 24-hour cortisol secretion patterns in prepubertal children with depression, anxiety, and normal controls, in light of their longitudinal clinical follow-up into young adulthood. Examining the childhood cortisol-secretion patterns of 20 subjects who had not been depressed youngsters, yet who developed a major depression as adults, she found that the patterns were essentially identical to the atypical childhood cortisol-secretion profile exhibited by the 50 subjects who had been depressed as youngsters. This finding implied that this abnormal childhood cortisol-secretion profile might be a biological marker not just for depression susceptibility during childhood, but also for depression susceptibility during adulthood, and raised the possibility of identifying, via childhood cortisol-secretion tests, individuals who were at risk for depression either during childhood or adulthood.

Treatment Studies
Treating Depressed Adolescents in a School-Based Clinic (L. Mufson, P.I.) The first effectiveness study of an Evidence-Based Treatment (EBT) for depressed adolescents in school based clinics (Interpersonal Psychotherapy [IPT-A] was completed and demonstrated the efficacy of 12 weeks of IPT-A, as compared to treatment as usual in reduction of symptoms and improvement in adolescent social functioning (Mufson et al, 2004). Mental health professionals without previous experience in EBT received on-the-job training. These findings suggest that the treatment of the large number depressed adolescents can be improved markedly by raising the standards of training of mental health professionals to use an evidence-based treatment in school settings. This work is being extended to school-based clinics in the New York City area and is being tested by Mufson against group IPT. Mufson et al. have revised her book describing the methods of IPT-A, soon to be published (Mufson et al, 2004).

Group IPT for Depressed Adolescents L. Mufson received a NARSAD award to adapt and pilot test group IPT for 18 depressed adolescents. Twenty 13-17 year old depressed adolescents were eligible to participate. The depressed adolescents are sequentially randomized to either group or individual IPT-A, depending upon which modality is being offered at that time.

Interpersonal Psychotherapy and Psychoeducation for Adolescent Children of Bipolar Mothers L. Verdeli received a NARSAD Young Investigator Award for this project. Twenty adolescents whose mothers have Bipolar I disorder are randomized to IPT and family psychoeducation or family psychoeducation and clinical monitoring.

A Counseling Intervention for Adolescent Children of Bipolar Mothers L. Verdeli was awarded the Sol Goldman Charitable Trust to conduct an open trial to test the feasibility of Interpersonal and Social Rhythm Counseling for adolescent children of Bipolar mothers.

Treatment of Depressed Mothers: A STAR*D Ancillary Study (M. Weissman, P.I., D. Pilowsky, co-P.I.) The overall aim of this NIMH ancillary study to the multi-site Sequenced Treatment Alternatives to Relieve Depression study (STAR-D) is to determine the impact of a reduction of maternal depressive symptoms on children’s psychiatric symptoms and social functioning. One hundred fifty one mother-child pairs have been enrolled into the study and baseline data on the first one hundred cases show the high rate of psychopathology among children of depressed mothers participating in STAR-D.

IPT for Prepubertal Depression D. Pilowsky, P.I., was awarded a grant from Klingenstein Foundation to develop the first adaptation of IPT for prepubertal children with depressive symptoms. A draft manual has been submitted to the Foundation.

Treatment of Depression in Uganda L. Verdeli, M. Weissman modified IPT in a group format for depressed patients in Uganda and Verdeli trained group leaders for a controlled clinical trial. The trial has been completed and showed the efficacy of IPT as compared to usual treatment. The manual is being disseminated to investigators in other developing countries.

Epidemiology/Health Services
Medication Management Decisions in Schizophrenia (M. Olfson, P.I.) This study seeks to understand why the medication management of schizophrenia so commonly departs from evidence based treatment recommendations. The study examines clinical decision making from a nationally representative random sample of 1,600 psychiatrists and focuses on the effects of selected modifiable patient, provider, and practice characteristics on the quality of antipsychotic prescription decisions.

Sexual Side-Effects of Antipsychotic Medications (M. Olfson, P.I.)This study seeks to determine the prevalence, severity, and clinical consequences of sexual side-effects associated with four antipsychotic medications that are commonly prescribed for the treatment of schizophrenia.

Columbia Center for the Health of Urban Minorities, Director Mental Health Research Core (M. Olfson) The overall aim of the Mental Health Research Core is to facilitate and evaluate mental health interventions for low income minority populations. Activities of the core focus on minority groups that have limited access to specialized mental health services. The MHRC pursues this aim through fostering collaborations between mental health researchers trained in service evaluation and community agencies that provide social and health services; promoting research on interventions to improve mental health care access for low income minority adults and children, and encouraging health and mental health researchers to extend their research into area relevant to reducing ethnic and racial disparities in access to mental health care.

Psychopharmacoepidemiology Research Unit (PERU) Dr. Olfson is the Director of PERU. The PERU mission is to increase knowledge of the use of prescribed psychotropic medications in children and adolescents through the examination of utilization patterns. Recent projects supported by the PERU include a national overview of psychotropic medication use in children; an examination of recent trends in the pharmacological treatment of ADHD; an analysis of the effects of parental depression on child mental health service utilization; a small geographic area evaluation of antidepressants use and suicide rates in the United States. A planned study involves using Medicaid claims and National Death Index Data to determine whether treatment with antidepressant medications and/or psychotherapy reduces the risk of suicide and suicide attempts in high-risk young people.

Medication Noncompliance in Schizophrenia (M. Olfson, P.I., C.Boyer Co-PI) This study involves a novel psychological approach to the treatment of medication noncompliance in schizophrenia. Outpatients who are receiving short-term inpatient care and have a recent history of medication non-compliance are being randomly assigned to receive compliance therapy or continued usual care. Compliance therapy draws on the principles of motivational interviewing to increase the patients' awareness of discrepancies between their current behavior and long-term goals.

Schizophrenia Treatment Guideline Implementation Project
(M. Olfson, P.I.) There is accumulating evidence that substantial numbers of patients with schizophrenia are prescribed antipsychotic medication regimens that are inconsistent with evidence-based treatment guidelines. We are conducting a treatment guideline implementation project to determine whether medication algorithms, clinical support, and academic outreach increase the quality of medication management for schizophrenia and improve patient outcomes. 120 patients with schizophrenia or schizoaffective disorder and 4 public mental health outpatient clinics in Brooklyn, NY are participating.

Psychiatric Disorder and Treatment in an Urban Primary Care Practice (M. Weissman, P.I., M. Olfson) This is a study of the frequency and treatment of bipolar disorder or other psychiatric disorders in 1000 adult patients at the Associates in Internal Medicine (AIMS) of the Columbia Presbyterian Medical Center serving urban, poor, adult, primary care patients. Data analysis is underway. A NARSAD grant was awarded to Y. Nuria to understand the relationship between PTSD and major depression in this sample. An NIMH grant was submitted by C. Blanco to develop an intervention for patients experiencing PTSD in this study. Roberto Lewis Fernando was awarded a NARSAD grant to follow up the Hispanic patients reporting psychotic symptoms.

EDUCATION AND TRAINING
Graduate Students
Sarah Bledsoe (Ph.D., Social Work)
Heidi Fitterling (M.P.H., Epidemiology)
Lena Lee (M.A., Clinical Psychology)
Ann Madsen (Ph.D. Epidemiology)
Dana March, M.P.H. (Ph.D. Epidemiology)
James Pierce, M.P.H. (Ph.D. Epidemiology)
Virginia Warner, M.P.H. (Ph.D. Epidemiology)

Psychiatric Residents
Melissa Arbuckle, M.D., Ph.D.
Drew Ramsey, M.D.

Medical Student
Karinn Glover

Post Doctoral Fellows
Amar Das, M.D., Ph.D. (Psychiatry)
James Gangwisch, Ph.D. (Epidemiology)
Eleanor Murphy, Ph.D. (Epidemiology)
Dvora Shmulewitz, Ph.D. (Statistical Genetics)
Lisa Strug, Ph.D. (Statistical Genetics)
Jamie Young, Ph.D. (Child Psychiatry)
Regina Zimmerman, Ph.D. (Statistical Genetics)

Training Grant (S. Hodge, P.I.) Genetic Analysis: Psychiatric & Other Complex Disorders.

Course Title and Description Professor
“Genetic Analysis Laboratory”
(Biostatistics P8148)
David Greenberg
“Psychiatry in Primary Care”
(bi-weekly course taught each month to PGY I Medicine Residents)
Adriana Feder
“Behavioral Medicine”
(weekly course taught each month to PGY II Medicine Residents)
Adriana Feder
“Evidence-based Psychotherapy Course”
(three-month course for adult psychology interns)
Helen Verdeli
“Cognitive Behavior Therapy”
(four-month course for graduate students at Teachers College)
Helen Verdeli
“Interpersonal Psychotherapy for Depression”
(Twelve-week course to PGY II Psychiatric Residents)
Helen Verdeli
“Evidence-based Psychotherapy Seminars”
(year-long weekly workshop for clinical and research child psychiatry fellows, staff and child psychology interns in psychiatry)
Laura Mufson
“Child Psychotherapy Techniques Seminar”
(year-long course for child psychology interns)
Laura Mufson
“Theoretical Genetic Modeling”
(Biostatistics P8139, one-semester graduate course)
Susan Hodge
“Statistical Aspects of Human Population Genetics”
(Biostatistics P8149, one-semester graduate course)
Susan Hodge
Case Conference on “Interpersonal Psychotherapy”
(monthly for fellows and faculty)
Myrna Weissman

CLINICAL SERVICES
Adriana Feder - psychiatric consultant to the Associates in Internal Medicine (AIM) Clinic, Columbia University Medical Center.

AWARDS AND HONORS
Adriana Feder was selected to present at the NARSAD 15th Annual Scientific Symposium. Presentation featured in Psychiatric News (December 19, 2003), Child’s Cortisol Level May Signal Depression Risk.
Laura Mufson, Ph.D. received the Klerman Young Investigator Award from the Depression & Bipolar Support Alliance Association.
David Greenberg, Ph.D. was one of 200 applicants selected by NIH to apply for the new Pioneer Research Award.
Weissman et al, 2004 paper on Panic Disorder and Interstitial Cystitis was featured in an article in Scientist.


Grants

Principal Investigator/Project Director Funding Agency/Grant #                   Title ProjectPeriod DirectCosts ($)
Feder, Adriana      (M. Weissman, Mentor) NARSAD The Neurobiology of Prepubertal Onset Depression 2002–2004 60,000
Greenberg, David NINDS/R01 NS27941 Multicenter Study of Idiopathic Generalized Epilepsy 2000–2005 600,000
Greenberg, David NIDDK/R01 DK31775 Two-locus Models, Heterogeneity and Diabetes 2003–2007 125,000
Feder, Adriana GlaxoSmithKline Screening for Posttraumatic Stress Disorder in Primary Care 2002–2004 66,667
Gross, Raz Pfizer Sertraline Treatment of Interstitial Cystitis: an Open Label Clinical Trial 2004–2005 80,000
Gross, Raz Irving Center Sertraline and Treatment of Interstitial Cystitis:A Pilot Study 2004–2005 10,000
Hodge, Susan NIDDK/R01 DK31813 Linkage and Segregation in Complex Genetic Diseases 2003–2008 425,000
Hodge, Susan NIMH/T32 MH65213 Genetic Analysis: Psychiatric and Other Complex Diseases 2002–2007 751,855
Matthew, Sanjay (M. Weissman, Mentor) Am Fdn Prev Suicide Neuroimaging Studies of Brain Structure and Function in Suicidal and Non-suicidal Depressed Adolescents Grown Up 2002–2004 69,960
Neria, Yuval (M. Weissman, Mentor) NARSAD Depression and PTSD in Primary Care Patients Exposed to the World Trade Center Attack 2003–2005 60,000
Nomura, Yoko(M. Weissman, Mentor) NARSAD Prenatal Problems and Low SES as Risk Factors for Comorbid Depression and other Medical Illness Across the Life Span 2004-2006 60,000
Mufson, Laura Columbia Univ Ctr Hlth of Urban Minorities Interpersonal Psychotherapy for Adolescent Depression: The Effect of Cultural Responsiveness, and Therapist Adherence and Competence on Treatment For Minority Students in School-based Health Clinics 2004 8,683
Olfson, Mark Janssen/Lilly Schizophrenia Treatment Guideline Implementation 1999–2004 540,000
Olfson, Mark Bristol Myers Squibb Sexual Dysfunction and Use of Antipsychotic Medications 2002–2004 160,000
Olfson, Mark NIMH/R01 MH61530 Medication Management Decisions in Schizophrenia 2001–2004 794,782
Olfson, Mark       Das, Amar Lilly Clinical Review of Issues in the Presentation, Recognition, Diagnosis, and Management of Depression in Adult Hispanics. 2003–2004 15,000
Olfson, Mark NCMHD #MD00206 P60 Core 7, Mental Health in: Columbia Center for the Health of Urban Minorities (CHUM) O Carrasquillo, PI 2003–2008 392,403
Pilowsky, Daniel Klingenstein Third Generation Foundation Interpersonal Psychotherapy for School-Age Children at Risk for Depression 2001–2004 50,000
Verdeli, Helena NARSAD A Prevention Intervention for Symptomatic Adolescent Children of Mothers with Bipolar Disorder 2000–2004 60,000
Verdeli, Helena Sol Goldman Charitable Trust Interpersonal Psychotherapy (IPT) for Adolescents of Bipolar Mothers: A Randomized Clinical Trial 2003–2005 80,000
Weissman, Myrna NIMH/R01 MH36197 Children at High and at Low Risk for Depression 2003–2007 2,958,660
Weissman, MyrnaFeder, Adriana NIMH MH36197 Minority supplement for Adriana Feder to: Children at High and at Low Risk for Depression 1999–2004 322,116
Weissman, Myrna NIMH/R37 MH28274 Genetic Studies of Depressive Disorders 2002–2004 529,826
Weissman, Myrna NIMH/R01 MH59537 Genetics of Recurrent Early-Onset Major Depression 1999–2004 959,182
Weissman, MyrnaPilowsky, Daniel NIMH/R01 MH63852 Children of Depressed Mothers: A STAR*D Ancillary Study 2001–2006 3,939,150
Weissman, Myrna NIMH/P30 MH43878 Psychotherapy Core of the Center Grant A Center to Study Interventions in Child Psychiatry@, David Shaffer, PI 1999–2004  627,758(core only)
Weissman, Myrna NIMH/P01 MH060970 Clinical Studies of Human Anxiety Disorders, a Project of the PPG A Molecular Genetic Study of Fear and Anxiety@, Conrad Gilliam, PI 2003–2006  900,948(prly)
Weissman, Myrna    Olfson, Mark Lilly Bipolar Spectrum Disorder in an Urban Multi-Ethnic Primary Care Practice 2001–2004 125,000
Weissman, MyrnaDas, Amar Lilly Clinical Review of Issues in the Presentation, Recognition, Diagnosis and Management of Depression in Adult African Americans 2003–2004 15,000
Weissman, Myrna NIMH/T32 MH16434 Research Training in Child Psychiatry (D. Shaffer, PI, M. Weissman, Co-PI) 2000–2005 1,756,707
Weissman, Myrna Josiah Macy Foundation Bridging the Gap Between Research & Clinical Practice 2003-2005 181,818
Young, Jaimie     (L. Mufson, Mentor) NARSAD Prevention of Depression in Early Adolescents: A Study of Interpersonal Therapy B Adolescent Skills Training 2003–2005 59,824


BIBLIOGRAPHY
Ahsan H, Hodge SE, Heiman GA, Susser E. Genetic linkage studies. In: Susser E, Schwartz S, Morabia A, Gorman J, Bromet E, eds. Psychiatric Epidemiology: Searching for Causes. New York: Oxford University Press. In press, 2004.

Ban Y, Greenberg DA, Concepcion E, Skrabanek L, Villanueva R, Tomer Y. Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc Natl Acad Sci U S A. In press, 2003.

Blanco C, Clougherty KF, Lipsitz KF, Mufson L, Weissman MM. Homework in interpersonal psychotherapy. In: Gabbard G, Beck J, Holmes J, eds. Journal of Psychotherapy Integration (Special Series): Integrating between-session homework activities into different psychotherapies. Concise Oxford Textbook of Psychotherapy. In press, 2003.

Bolton P, Bass J, Neugebauer R, Clougherty KF, Verdeli H, Wickramaratne PJ, Ndogoni L, Speelman L,
Weissman MM. Group interpersonal psychotherapy for depression in rural Uganda. A randomized controlled trial. JAMA. 2003;289:3117-3124.

Charney DS, Reynolds III CF, Lewis L, Lebowitz BD, Sunderland T, Alexopoulos GS, Blazer DG, Katz IR, Meyers BS, Arean PA, Borson S, Brown C, Bruce ML, Callahan CM, Charlson ME, Conwell Y, Cuthbert BN, Devanand DP, Gibson MJ, Gottlieb GL, Krishnan KR, Laden SK, Lyketsos CG, Mulsant BH, Niederehe G, Olin JT, Oslin DW, Pearson J, Persky T, Pollock BG, Raetzman S, Reynolds M, Salzman C, Schulz R, Schwenk TL, Scolnick E, Unützer J, Weissman MM, Young RC. Depression and bipolar support alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry. 2003;60:664-672.

Cheng R, Park N, Hodge SE, Juo S-H H. Comparing two methods to analyze longitudinal linkage data from the Framingham Family Study. Genetic Analysis Workshop 13. BMC Genet. 2003;4(Suppl 1):S20.

Clougherty KF, Verdeli H, Weissman MM. Interpersonal psychotherapy for a group in Uganda (IPTGU). Copyrighted unpublished manual, 2003.

Das A, Gross R, Weissman MM. Screening for depression in adults. [Letter to the Editor.] Ann Intern Med. 2003;138:767.

Feder A: Hysteria. In: Aminoff MJ, Daroff R(Eds). Encyclopedia of the NeurologicalSciences. Academic Press, 2003, pp. 629-631.

Feder A, Coplan JD, Goetz RR, Mathew SJ, Pine DS, Dahl RE, Ryan ND, Greenwald S, Weissman MM.
Twenty-four hour cortisol secretion patterns in prepubertal children with anxiety or depressive disorders. Biol Psychiatry. In press, 2004.

Feder A, Goetz RR, Coplan JD, Mathew SJ, Pine DS, Greenwald S, Dahl RE, Ryan ND, Weissman MM.
A reanalysis of 24-hour cortisol secretion in prepubertal children with or without major depression in light of adult clinical follow-up data (Abstract). Biol Psychiatry 2003;53:49S.

Feder A, Robbins SW, Ostermeyer B: Personality Disorders: In: Feldman MD, Christensen JF (Eds). Behavioral Medicine in Primary Care; A Practical Guide. McGraw-Hill, 2003, pp 231-252.

Feenstra B, Greenberg DA, Hodge SE. Using lod scores to detect sex differences in male-female recombination fractions. Hum Hered. In press, 2004.

Flodman P, Hodge SE. Sex-specific mutation rates for X-linked disorders: Estimation and application. Hum Hered. 2003;55:51–55.

Goodwin RD, Olfson M, Shea S, Lantigua RA, Carrasquillo O, Gameroff MJ, Weissman MM. Asthmaand mental disorders in primary care.Gen Hosp Psychiatry. 2003 Nov-Dec;25(6):479-83.

Hamilton SP, Fyer AJ, Durner M, Heiman GA, de Leon AB, Hodge SE, Knowles JA, Weissman MM. Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q. PNAS. 2003;100:2550–2555.

Hamilton SP, Slager SL, Baisre de Leon A, Heiman GA, Klein DF, Hodge SE, Weissman MM, Fyer AJ, Knowles JA. Evidence for genetic linkage between a polymorphism in the Adenosine 2A receptor (ADORA2A) and panic disorder. Neuropsychopharmacology. 2004; 29:588-565.

Hamilton SP, Slager SL, Mayo D, Heiman GA, Klein DF, Hodge SE, Fyer AJ, Weissman MM, Knowles JA. Investigation of polymorphisms in the CREM gene in panic disorder. Neuropsychiatric Genetics. 2004; 1268:111-115.

Holmans P, Zubenko GS, Crowe RR, DePaulo JR, Scheftner WA, Weissman MM, Zubenko WN, Boutelle S, Murphy-Eberenz K, Mackinnon D, McInnis MG, Marta DH, Adams P, Knowles JA, Gladis M, Thomas J, Chellis J, Miller E, Levinson DF. Genowide significant linkage to recurrent, early-onset major depressive disorder on chromosome 15q. Am J Hum Genet 74: 1154-1167, 2004.

Levinson DF, Zubenko GS, Crowe RR, DePaulo JR, Scheftner WS, Weissman MM, Holmans P, Zubenko WN,
Boutelle S, Murphy-Eberenz K, MacKinnon D, Marta DH, Adams P, Knowles JA, Thomas J, Chellis J. Genetics of Recurrent Early Onset Depression (GenRED): Design and preliminary clinical characteristics of a repository sample for genetic linkage studies. Am J Med Genet. 2003;119(B):118-130.

Lindholm E, Zhang J, Hodge SE, Greenberg DA. The reliability of haplotyping inference in nuclear families: Misassignment rates for SNPs and microsatellites. Hum Hered. In press.

March D, Yonkers KA. Panic disorder during pregnancy. Mental Fitness. 2004;3:43-51.

Mathew SJ, Coplan JD, Goetz RR, Feder A, Greenwald S, Dahl RE, Ryan ND, Mann JJ, Weissman MM.
Differentiating depressed adolescent twenty-four hour cortisol secretion in light of their adult clinical outcome (Abstract). Biol Psychiatry 2003;53:169S.

Mathew SJ, Coplan JD, Goetz RR, Feder A, Greenwald S, Dahle RE, Ryan ND, Mann JJ, Weissman
MM. Differentiating depressed adolescent twenty-four hour cortisol secretion in light of their adult clinical outcome. Neuropsychopharmacology 2003;28(7):1336-1343.

Mojtabai R, Olfson M. Medication costs, adherence, and health outcomes among Medicare enrollees. Health Aff. 2003;22:220-229.

Mufson, L. Interpersonal psychotherapy for depressed adolescents. In: Ollendick T, Schroeder C, eds. Encyclopedia of Pediatric and Child Psychology. New York: Kluwer Academic; 2003:320-322.

Mufson L, Gallagher T, Pollack-Dorta K, Young JF. Interpersonal psychotherapy for adolescent depression: Adaptation for group therapy. Am J Psychother. In press.

Mufson L, Pollack-Dorta K. Interpersonal psychotherapy for depressed adolescents. In: Kazdin A, Weisz J, eds. Evidence-based Psychotherapies for Children and Adolescents. New York: Guilford Publications; 2003:148-164.

Mufson L, Pollack-Dorta KE, Moreau D, Weissman MM. Efficacy to effectiveness: Adaptations of interpersonal psychotherapy for adolescent depression. In: Hibbs ED, Jensen PS, eds. Psychosocial Treatments for Child and Adolescent Disorders: Empirically-based Strategies for Clinical Practice, Second Edition. American Psychological Association. In press, 2004.

Mufson L, Pollack-Dorta K, Moreau D, Weissman, MM. Interpersonal Psychotherapy for Depressed Adolescents, Second Edition. New York: Guilford Publications. 2004.

Mufson, L., Pollack Dorta K., Wickramaratne P., Nomura Y., Olfson M., Weissman MM. The Effectiveness of Interpersonal Psychotherapy for Depressed Adolescents. Archives of General Psychiatry. 2004;61:577-584.

Mufson L, Pollack-Dorta KE, Wickramaratne PJ, Nomura Y, Olfson M, Weissman MM. A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry. In press, 2004.

Olfson M, Gameroff MJ, Marcus SC, Waslick BD. Treatment of childhood depression in the United
States. Arch Gen Psychiatry. 2003;60:1236-1242.

Olfson M, Marcus SC, Druss B, Pincus HA, Weissman MM. Parental depression, child mental health problems,
and health care expenditures. Med Care. 2003;41:716-721.

Olfson M, Marcus SC, Gameroff MJ, Jensen PS. National trends in the treatment of attention deficit/hyperactivity disorder. Am J Psychiatry. 2003;160:1071-1077.

Olfson M, Shaffer D, Marcus SC, Greenberg T. Relationship of antidepressant medication use to suicide in
adolescents. Arch Gen Psychiatry. 2003;60:978-982.

Olfson M, Tobin JN, Cassells A, Weissman MM. Improving the detection of drug abuse, alcohol abuse and
depression in community health centers. J Health Care Poor Underserved. 2003;14:386 402.

Pal DK, Evgrafov OV, Tabares P, Zhang F, Durner M, Greenberg DA. BRD2 (RING3) is a probable major
susceptibility gene for common juvenile myoclonic epilepsy. Am J Hum Genet. 2003;73:261-70.

Pilowsky DJ, Birmaher B, Weissman MM. Approaches to chronic depression in children and adolescents. In:
Alpert J, Fava M, eds. Handbook of Chronic Depression. New York: Marcel Dekker, Inc.; 2004:339-362.

Sohler N, Walkup J, McAlpine D, Boyer CA, Olfson M. Antipsychotic medication dosing at hospital discharge
and outcomes for persons with schizophrenia. Psychiatr Serv. 2003;54:1258-1263.

Spence MA, Greenberg DA, Hodge SE, Vieland VJ. The emperor's new methods. Am J Hum Genet.
2003;72:1084-1087.

Spence MA, Hodge SE. Segregation analysis. In: Rimoin DL, Connor JM, Pyeritz RE, Korf BR. Emery and
Rimoin's Principles and Practice of Medical Genetics, 4th edition. London: Churchill Livingstone; 2002:125-132.

Verdeli H, Clougherty K, Bolton P, Speelman L, Ndogoni L, Bass J, Neugebauer R, Weissman MM. Adapting
group interpersonal psychotherapy (IPT G) for a developing country: Experience in rural Uganda. World Psychiatry. 2003;2:114 120.

Verdeli H, Ferro T, Wickaramaratne P, Greenwald S, Blanco C, Weissman MM. Treatment of depressed mothers
of depressed children: A pilot study of feasibility. Depress Anxiety. 2004;19:51-59.

Villanueva R, Greenberg DA, Davies TF, Tomer Y. Sibling recurrence risk in autoimmune thyroid disease.
Thyroid. 2003;8:761-764.

Weissman MM. The epidemiology of bipolar disorder. In: Goodwin F, Jamison K, eds. Manic Depressive Illness.
Oxford University Press. In press, 2004.

Weissman MM. Interpersonal psychotherapy for major depression. Therapy Advisor [website]; 2004.

Weissman MM. Phobias in primary care and in young children. [Commentary on: Demyttenaere K, Bruffaerts R,
De Witte. A Social and economic burden of phobias.] In: Maj M, Akiskal HS, eds. Phobias/Vol 7 World Psychiatric Association Series Evidence and Experience in Psychiatry. Wiley and Chichester. In press, 2004.

Weissman MM. The psychotherapy of bipolar disorder. In: Goodwin F, Jamison K, eds. Manic Depressive Illness. Oxford University Press. In press, 2004.

Weissman MM, Bland R, Canino G, Faravelli C, Greenwald S, Hai-Guo H, Joyce PR, Karam EG, Chung-Kyoon
L, Lellouch J, Lépine J, Newman S, Rubio-Stipec M, Wells JE, Wickramaratne PJ, Wittchen H, Dung YE. Women’s increased vulnerability to major depression: Cross-national perspective. In: Moussaoui D, Lopez-Ibor JJ, Okasha A, Maj M, eds. WPA Bulletin on Depression (10 Yr Special Issue). 2003:12-16.

Weissman MM, Feder AJ, Pilowsky D, Olfson M, Fuentes M, Blanco C, Lantigua R, Gameroff MJ, Shea S.
Depressed mothers coming to primary care: Maternal reports of problems with their children. J Affect Disord. 2004;78:93-100.

Weissman MM, Gross R, Fyer AJ, Heiman GA, Gameroff MJ, Kaufman D, Kaplan SA. Interstitial cystitis and panic disorder: A potential genetic syndrome. Arch Gen Psychiatry. 2004;61:273-279.

Weissman MM, Sanderson WC. Promises and problems in modern psychotherapy: The need for increased
training in evidence-based treatments. In: Hager M, ed. Modern Psychiatry: Challenges in Educating Health Professionals to Meet New Needs. New York: Macy Foundation; 2003 (Session 2):132-165.

Weissman MM, Warner V, Wickramaratne PJ, Nomura Y, Merikangas K, Bruder G, Tenke CE, Grillon C. Offspring at high risk for anxiety and depression: Preliminary findings from a three generation study. In: Gorman J, ed. Fear and Anxiety: Benefits of Translational Research. Washington DC: American Psychiatric Association Press, Inc. January, 2004, pp 65-83.

Wilson JJ, Nunes EV, Greenwald S, Weissman MM. Verbal deficits and disruptive behavior disorders among children of opiate dependent parents. Amer J Addictions 13:202-22, 2004.

Wilson JJ, Pine DS, Cargan A, Goldstein RB, Nunes EV, Weissman MM. Neurological soft signs and disruptive behavior among children of opiate dependent parents. Child Psychiat Hum Developm 34(1): 19-34, 2003.

Yonkers KA, March D. Treatment of premenstrual dysphoric disorder. J Gend Specif Med. In press, 2004.

Yonkers KA, March D. Treatment of premenstrual dysphoric disorder. Mental Fitness. 2003;2:20-28.

Young JF, Mufson L. Interpersonal psychotherapy for adolescent depression: A guide to techniques and implementation. In: Steiner H. ed. Handbook on Mental Health Interventions in Children and Adolescents: An Integrated Developmental Approach. Wiley & Co., 2004.